loadpatents
name:-0.040653944015503
name:-0.0083510875701904
name:-0.0048491954803467
Vasilakos; John P. Patent Filings

Vasilakos; John P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vasilakos; John P..The latest application filed is for "sesame oil based injection formulations".

Company Profile
1.8.21
  • Vasilakos; John P. - Woodbury MN
  • Vasilakos; John P. - St. Paul MN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Sesame Oil Based Injection Formulations
App 20210244819 - Beaurline; Joseph M. ;   et al.
2021-08-12
Sesame oil based injection formulations
Grant 11,020,486 - Beaurline , et al. June 1, 2
2021-06-01
Beta-glucan Compounds, Compositions, And Methods
App 20180256738 - Bose; Nandita ;   et al.
2018-09-13
Beta-glucan compounds, compositions, and methods
Grant 9,943,607 - Bose , et al. April 17, 2
2018-04-17
Sesame Oil Based Injection Formulations
App 20160271259 - BEAURLINE; Joseph M. ;   et al.
2016-09-22
Therapeutic Combinations And Methods Including Irm Compounds
App 20150110784 - Tomai; Mark A. ;   et al.
2015-04-23
Therapeutic combinations and methods including IRM compounds
Grant 8,940,755 - Tomai , et al. January 27, 2
2015-01-27
Beta-glucan Compounds, Compositions, And Methods
App 20140370046 - Bose; Nandita ;   et al.
2014-12-18
Therapeutic Compositions And Methods
App 20120288495 - Vasilakos; John P.
2012-11-15
Selective modulation of TLR-mediated biological activity
Grant 7,485,432 - Fink , et al. February 3, 2
2009-02-03
Methods and compositions related to IRM compounds and Toll-like receptor 8
Grant 7,375,180 - Gorden , et al. May 20, 2
2008-05-20
Compositions and methods for targeted delivery of immune response modifiers
App 20060142202 - Alkan; Sefik ;   et al.
2006-06-29
Screening method for identifying compounds that selectively induce interferon alpha
App 20060009482 - Tomai; Mark A. ;   et al.
2006-01-12
Methods and compositions related to IRM compounds and toll-like receptor pathways
App 20050245564 - Gorden, Keith B. ;   et al.
2005-11-03
Therapeutic combinations and methods including IRM compounds
App 20050226878 - Tomai, Mark A. ;   et al.
2005-10-13
Therapeutic combinations and methods including IRM compounds
App 20050171072 - Tomai, Mark A. ;   et al.
2005-08-04
Immunomodulatory combinations
App 20050158325 - Hammerbeck, David M. ;   et al.
2005-07-21
Neutrophil activation by immune response modifier compounds
App 20050096259 - Tomai, Mark A. ;   et al.
2005-05-05
Immunostimulatory combinations and treatments
App 20050048072 - Kedl, Ross M. ;   et al.
2005-03-03
Selective modulation of TLR-mediated biological activity
App 20040171086 - Fink, Jason R. ;   et al.
2004-09-02
Methods and compositions related to IRM compounds and toll-like receptor 8
App 20040162309 - Gorden, Keith B. ;   et al.
2004-08-19
Methods and compositions related to IRM compounds and toll-like recptor pathways
App 20040014779 - Gorden, Keith B. ;   et al.
2004-01-22
Maturation of dendritic cells with immune response modifying compounds
App 20030186440 - Tomai, Mark A. ;   et al.
2003-10-02
Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
App 20030133913 - Tomai, Mark A. ;   et al.
2003-07-17
Maturation of dendritic cells with immune response modifying compounds
Grant 6,558,951 - Tomai , et al. May 6, 2
2003-05-06
Screening method for identifying compounds that selectively induce interferon alpha
App 20020110840 - Tomai, Mark A. ;   et al.
2002-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed